FIG 1.

MIC frequency distribution of ceftazidime-avibactam and ceftazidime against ceftazidime-resistant Enterobacteriaceae isolated from patients enrolled in the phase 3 clinical trial.

MIC frequency distribution of ceftazidime-avibactam and ceftazidime against ceftazidime-resistant Enterobacteriaceae isolated from patients enrolled in the phase 3 clinical trial.